Who
David M. Denton
EVP: CFO
Company insider
Files Form 4 as: EVP: CFO, Nike; Director, Honeywell Aerospace; Chief Financial Officer & EVP, Pfizer; Director, Tapestry; EVP, Chief Financial Officer, Lowe's Companies; EVP and CFO, CVS Health.
In numbers
- Trades disclosed
- 171
- Buys
- 1
- Sells
- 8
- Bought
- $50K
- Sold
- $54.5M
- Companies
- 6
- Companies where not an officer
- 2
- First trade
- 5 Mar 2008
- Last trade
- 1 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 3 Sep 2026 | NKE NikeApparel, Footwear & Luxury | SEC FORM 4 Code A | —71,234 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | NKE Nikeoption or derivative · Apparel, Footwear & Luxury | SEC FORM 4 Code A | —259,946 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | NKE Nikeoption or derivative · Apparel, Footwear & Luxury | SEC FORM 4 Code A | —259,946 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | NKE NikeApparel, Footwear & Luxury | SEC FORM 4 Code A | —71,234 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | HONA Honeywell Aerospaceoption or derivative · Aerospace & Defense | SEC FORM 4 Code A | —572 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | HONA Honeywell Aerospaceoption or derivative · Aerospace & Defense | SEC FORM 4 Code A | —572 at $0.00 | filing |
| 29 Jun 2026filed 1 Jul 2026 | HONA Honeywell Aerospaceoption or derivative · Aerospace & Defense | SEC FORM 4 Code A | $31K135.144 at $226.24 | filing |
| 29 Jun 2026filed 1 Jul 2026 | HONA Honeywell Aerospaceoption or derivative · Aerospace & Defense | SEC FORM 4 Code A | $31K135.14 at $226.24 | filing |
| 3 Mar 2026filed 5 Mar 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —216,537 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —216,537 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2025 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —413,138 at $0.00 | filing |
| 12 Sep 2024filed 16 Sep 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —103,320 at $0.00 | filing |
| 12 Sep 2024filed 16 Sep 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —103,320 at $0.00 | filing |
| 12 Sep 2024filed 16 Sep 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code D | —80,703 at $0.00 | filing |
| 12 Sep 2024filed 16 Sep 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —80,703 at $0.00 | filing |
| 31 May 2024filed 3 Jun 2024 | PFE PfizerPharmaceuticals | SEC FORM 4 Code F | $347K12,107 at $28.66 | filing |
| 27 Feb 2024filed 28 Feb 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —161,160 at $0.00 | filing |
| 27 Feb 2024filed 28 Feb 2024 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —142,400 at $0.00 | filing |
| 31 May 2023filed 1 Jun 2023 | PFE PfizerPharmaceuticals | SEC FORM 4 Code F | $617K16,223 at $38.02 | filing |
| 23 Feb 2023filed 24 Feb 2023 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —103,320 at $0.00 | filing |
News
Dividend Roundup: Johnson & Johnson, Coca-Cola, Costco, CVS Health, and moreCVS · seekingalpha.com · 16 Oct 2026CVS Health: CVS Caremark Is Transforming the Health Care ExperienceCVS · finanznachrichten.de · 16 Oct 2026CVS Health - Early Detection Matters: Finding Heart Health Risks EarlierCVS · finanznachrichten.de · 15 Oct 2026
0 headlines in the last 90 days name David M. Denton; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.